| Literature DB >> 34299943 |
Abstract
Given its highly contagious nature and an absence of a specific antiviral agent to this date, the key to controlling the spread of coronavirus disease 2019 (COVID-19) and decreasing the infection rate is adherence to preventive measures. It is essential to understand an individual's knowledge, attitudes and practices toward COVID-19 since public adherence to health guidelines relies heavily on these aspects. However, there is no validated instrument that evaluates knowledge, attitudes and practices toward COVID-19. Thus, this study aimed to develop and validate such tool. A questionnaire was developed based on international and national guidelines and a review of the literature. Initial items were evaluated by 10 experts to determine content validity. Exploratory factor analysis and reliability testing were conducted with a convenience sample of 229 nursing students. Based on the content, face validity and factor analysis, 34 items were selected. The Kaiser-Meyer-Olkin value of 0.735 indicated a highly acceptable score with a significant Bartlett's test of sphericity (p < 0.0001). The internal consistency coefficients indicated acceptable reliability of the tool (Cronbach's α = 0.75). The KAP COVID-19 is a valid instrument that can be used to evaluate knowledge, attitudes and practices toward COVID-19.Entities:
Keywords: COVID-19; attitudes; instrument development and validation; knowledge; practice
Mesh:
Year: 2021 PMID: 34299943 PMCID: PMC8303280 DOI: 10.3390/ijerph18147493
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1A flow diagram of the development and validation process.
Characteristics of study participants.
| Characteristics | ( |
|---|---|
| Age (years), M ± SD (range) | 21.1 ± 1.7 (18–33) |
| Gender, n (%) | |
| Female | 210 (91.7) |
| Male | 19 (8.3) |
| Grade, n (%) | |
| Freshman | 26 (11.4) |
| Sophomore | 40 (17.5) |
| Junior | 95 (41.5) |
| Senior | 68 (29.7) |
| KAP COVID-19 | |
| Knowledge scale, M ± SD (range) | 8.9 ± 2.0 (3–13) |
| Attitude scale, M ± SD (range) | 32.8 ± 6.9 (16–46) |
| Practices scale M ± SD (range) | 41.4 ± 7.7 (19–56) |
| Total score, M ± SD (range) | 83.1 ± 11.1 (50–110) |
KAP: Knowledge, Attitudes and Practices.
Content validity index (CVI) rating of the individual KAP COVID-19 items.
| Item | I-CVI |
|---|---|
|
| |
|
COVID-19 is a respiratory syndrome caused by SARS-CoV2 virus infection | 1.0 |
|
The SARS-CoV-2 is an RNA virus belonging to Coronaviridae family | 1.0 |
|
COVID-19 is classified as a first-class infectious disease | 0.4 † |
|
Other than the main clinical symptoms of COVID-19, patients may also experience sore throat, headache, nausea and diarrhea | 0.8 |
|
COVID-19 always cause severe acute respiratory complications | 0.8 |
|
COVID-19 is currently being diagnosed using sequencing method | 0.8 |
|
COVID-19 is currently being diagnosed using a real-time reverse transcriptase polymerase chain reaction (Real-Time PCR) test | 0.9 |
|
Current treatment for COVID-19 is symptomatic treatment (treating the symptoms of a disease) including fluid supplementation, administration of antipyretic drugs, etc. | 1.0 ‡ |
|
A targeted therapy is available for SARS-CoV-2 | 0.9 |
|
To this date, there is no antiviral agent specific to SARS-CoV-2 | 1.0 |
|
COVID-19 is spread through droplet transmission | 0.5 † |
|
If a symptomatic patient tests negative for SARS-CoV-2, he/she must follow self-quarantine guidelines (i.e., remain at home, stay away from others including family members, etc.) for 14 days after the onset of symptoms | 0.8 ‡ |
|
Medical treatments and self-quarantine are not required if suspected patients (i.e., individuals displaying clinical symptoms within 14 days of contact with confirmed COVID-19 patients) test negative on PCR tests | 0.9 ‡ |
|
As a precautionary measure, one should avoid touching eyes, nose and mouth | 1.0 |
|
As a precautionary measure, surrounding environment should be disinfected and ventilated frequently | 1.0 |
|
| |
|
I believe that COVID-19 can be prevented if I follow Korean government’s guidelines | 1.0 |
|
I believe that COVID-19 can be prevented if I follow WHO guidelines | 0.9 |
|
I believe that COVID-19 can be prevented if I follow CDC guidelines | 0.8 |
|
Healthcare providers’ active participation in hospital infection control guidelines can reduce the spread of COVID-19 | 1.0 |
|
All pertinent information about COVID-19 should be shared among healthcare providers | 1.0 |
|
Healthcare providers should be aware of all pertinent information about COVID-19 | 0.8 |
|
Confirmed COVID-19 patients should receive immediate and prompt medical care | 1.0 |
|
| |
|
I wash my hands more frequently than usual | 1.0 |
|
I try to thoroughly wash my hands with soap and water for at least 30 s | 1.0 |
|
I use hand sanitizers more frequently than usual | 1.0 |
|
I consciously cover my nose and mouth with tissue, handkerchief or cloth when I cough or sneeze | 1.0 |
|
I consciously avoid touching my eyes, nose and mouth as much as possible. | 1.0 |
|
I minimize and avoid using public transportation as much as possible | 0.9 |
|
I feel reluctant to use public transportation | 0.9 |
|
I avoid going out as much as possible | 0.8 |
|
I avoid crowded places (e.g., restaurants, department stores, shopping malls, bars, clubs, etc.) as much as possible | 0.9 |
|
I have cancelled or postponed personal and social activities such as meeting, gathering, dining out, shopping, travelling with family, friends and acquaintances to reduce contacting other people | 1.0 |
|
I avoid physical contact (e.g., handshakes, hugs, etc.) with others as much as possible, and maintain at least 2 m physical distance with others | 0.9 |
|
If I feel unwell, I avoid going out and stay home for 3~4 days | 1.0 |
|
Other than clinical practicum hours, I avoid visiting hospitals or pharmacies as much as possible | 0.8 |
|
I avoid walking around the neighborhood or visiting other neighborhood areas | 0.7 |
† deleted item; ‡ revised item.
Results of the exploratory factor analysis.
| Factor | Item | Factor Loading a | Eigenvalue | VE (%) | CVE (%) | Cronbach’s α |
|---|---|---|---|---|---|---|
|
| 0.532 b | |||||
| Nature of the disease | 1 | 0.781 | 4.219 | 12.409 | 12.409 | |
| 2 | 0.534 | |||||
| Signs and symptoms | 3 | 0.744 | 2.693 | 7.922 | 20.331 | |
| 4 | 0.651 | |||||
| Diagnosis | 5 | 0.657 | 2.545 | 7.485 | 27.816 | |
| 6 | 0.854 | |||||
| Medical management | 7 | 0.554 | 2.235 | 6.575 | 34.391 | |
| 8 | 0.677 | |||||
| 9 | 0.742 | |||||
| PUI management and quarantine | 10 | 0.751 | 1.678 | 4.963 | 39.326 | |
| 11 | 0.823 | |||||
| Precautionary strategy | 12 | 0.851 | 1.585 | 4.663 | 43.989 | |
| 13 | 0.820 | |||||
|
| 0.720 | |||||
| Beliefs about COVID-19 prevention | 14 | 0.897 | 1.541 | 4.531 | 48.521 | |
| 15 | 0.963 | |||||
| 16 | 0.901 | |||||
| Beliefs about healthcare provider role | 17 | 0.496 | 1.481 | 4.355 | 52.875 | |
| 18 | 0.810 | |||||
| 19 | 0.731 | |||||
| 20 | 0.701 | |||||
|
| 0.851 | |||||
| Personal hygiene practices | 21 | 0.716 | 1.400 | 4.117 | 56.992 | |
| 22 | 0.748 | |||||
| 23 | 0.593 | |||||
| 24 | 0.605 | |||||
| 25 | 0.561 | |||||
| Restricting behavior | 26 | 0.587 | 1.296 | 3.811 | 60.803 | |
| 27 | 0.512 | |||||
| 28 | 0.778 | |||||
| 29 | 0.781 | |||||
| 30 | 0.651 | |||||
| 31 | 0.680 | |||||
| 32 | 0.517 | |||||
| 33 | 0.621 | |||||
| 34 | 0.694 | |||||
VE, variance explained; CVE, cumulative variance explained; PUI, person under investigation. a Extraction method: principal component analysis. Rotation method: varimax with Kaiser normalization. Factor loading cut-off: >0.40. b Kuder-Richardson-20 coefficient.